US EditionImplantable device helps stabilize blood pressure in spinal cord injury patients
The implantable neurostimulation system restores stable blood pressure rapidly and is supported by a pivotal trial approved by the FDA involving about 20 centers internationally.
8 Articles
8 Articles
Global News
The Hamilton SpectatorResearch studies say implant can regulate blood pressure in spinal cord injuries
Aaron Phillips, an associate dean with the Calgary medical school, says the implant similar to a pacemaker delivers electrical stimulation and a regulation of blood pressure.
Implantable neurostimulation system restores blood pressure balance after spinal cord injury
Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs. In 2022, Krebs experienced a severe spinal cord injury (SCI) in a motor vehicle accident. Since that time, Krebs requires the use of a wheelchair. The damage to his spinal cord means his brain can no longer control blood pressure in his body. He was vulnerable to blood pressure drops where he was at risk of losing consciousness, and sp…
Of course, the worst thing about a spinal cord injury is being unable to walk. But there's another, equally devastating problem: unstable, chronically low blood pressure. And scientists have now devised a solution for that. More than forty percent of people with a spinal cord injury struggle with blood pressure problems. It leads to […] Want to know more about science? Read the latest articles on Scientias.nl .
New implant restores blood pressure balance after spinal cord injury
18.09.2025 - Neuroscientists and neurosurgeons from Canada, Switzerland and the Netherlands collaborate on life-changing research and innovation. Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs.
Groundbreaking Spinal Cord Therapy Controls Blood Pressure in SCI Patients: ONWARD's 2-Year Study Success
Clinical studies show ONWARD's ARC-IM System improves blood pressure stability in SCI patients, with benefits lasting up to 2 years. 78% of tetraplegics affected, FDA approves pivotal trial with 60 participants.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
